News about Global Pharma

FDA Appoints Dr. George F Tidmarsh as Director of Center for Drug Evaluation and Research

The US Food and Drug Administration (FDA) has appointed Stanford faculty member Dr. George Francis Tidmarsh as the new Director of the Center for Drug Evaluation and Research (CDER).

Global Pharma | 21/07/2025 | By Dineshwori |  664

CorestemChemon Partners with ATG Lifetech to Expand Global CRO Footprint

CorestemChemon, a South Korea–based GLP-certified preclinical CRO, has partnered with ATG Lifetech to co-develop advanced transcriptome and organoid-based platforms, aiming to deliver precision-driven, next-gen preclinical solutions to global pharma and biotech clients.

Global Pharma | 21/07/2025 | By Mrinmoy Dey |  188

Alembic Pharma Appoints Dr. Sachin Ghosalkar as Senior VP - SCM and Operations

Alembic Pharmaceuticals Ltd. has announced the appointment of Dr. Sachin Ghosalkar as Senior Vice President – Supply Chain Management (SCM) and Operations, designated as Senior Management Personnel of the company.

Global Pharma | 21/07/2025 | By Dineshwori |  511

Moderna Halts Plans for mRNA Manufacturing Facility in Japan Amid Business Uncertainty

The US-based vaccine maker announced on Friday that it would not proceed with its project at the Shonan Health Innovation Park (iPark) in Fujisawa, Kanagawa Prefecture. The decision follows “careful consideration given the current business environment,” according to a statement from Moderna’s Japan unit.

Global Pharma | 21/07/2025 | By Darshana |  424

FDA Drug Approvals Fall in 2024, But Small Pharma Fuels Innovation Surge

The US Food and Drug Administration (FDA) approved 127 innovator and biosimilar drugs in 2024, marking a decline from the 149 approvals recorded in 2023, according to a report by leading data and analytics firm GlobalData.

Global Pharma | 19/07/2025 | By Dineshwori |  576

India's Rising Role in the Global Pharma Supply Chain

One of the key drivers behind India’s growing role is its expansive manufacturing infrastructure. The country is home to more than 3,000 pharmaceutical companies and over 10,500 manufacturing units.

Global Pharma | 19/07/2025 | By Darshana |  339

Pharma Leaders Back UK Life Sciences Strategy, But ABPI Warns of Medicines Investment Gap

Pharmaceutical and medical technology leaders, including GSK, Sandoz, Accord Healthcare, Becton Dickinson, and Celltrion have welcomed the UK government’s new Life Sciences Sector Plan, recently unveiled as part of its flagship Industrial Strategy.

Global Pharma | 19/07/2025 | By Dineshwori |  292

Mallinckrodt Secures Irish High Court Approval for Merger with Endo

Mallinckrodt plc has announced that it has received the final ruling from the Irish High Court, clearing the way for its merger with Endo, Inc. to form a global, diversified therapeutics company.

Global Pharma | 19/07/2025 | By Mrinmoy Dey |  346

Cipla Appoints BNP and Associates as Secretarial Auditors for Five-Year Term

Cipla Limited has appointed M/s BNP and Associates as its Secretarial Auditors for a five-year term, commencing from the conclusion of the company’s 89th Annual General Meeting (AGM) and continuing until the conclusion of the 94th AGM.

Global Pharma | 19/07/2025 | By Dineshwori |  320

Oragenics, Sterling Pharma Solutions Ink Manufacturing Deal for Concussion Drug

Oragenics has partnered with Sterling Pharma Solutions for the GMP production of its lead drug candidate, ONP-002, for the treatment of concussion.

Global Pharma | 18/07/2025 | By Dineshwori |  311